Showing 1,101 - 1,120 results of 6,439 for search '"Heart"', query time: 0.08s Refine Results
  1. 1101
  2. 1102
  3. 1103
  4. 1104

    Layperson-Oriented versus Clinical-Based Models for Assessing 10-Year Incidence of Coronary Heart Disease: National FINRISK Study by Qing Qiao, Tiina Laatikainen, Weiguo Gao, Janne Pitkäniemi, Erkki Vartiainen

    Published 2011-01-01
    “…During the followup 1134 men and 566 women developed coronary heart disease (CHD). The area under the receiver operating characteristic curve (95% CI) for prediction of CHD incidence was 0.823 (0.807–0.839) for the laboratory-based model, 0.808 (0.791–0.824) and 0.803 (0.787–0.820) for the non-laboratory-based models with and without systolic blood pressure in men (P<0.01 for overall comparison), and 0.878 (0.856–0.901), 0.871 (0.848–0.894), and 0.864 (0.840–0.887), respectively, in women (P<0.01). …”
    Get full text
    Article
  5. 1105

    Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review by Marouane Boukhris, Salvatore Davide Tomasello, Francesco Marzà, Sonia Bregante, Francesca Romana Pluchinotta, Alfredo Ruggero Galassi

    Published 2014-01-01
    “…Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. …”
    Get full text
    Article
  6. 1106

    Increased cardiac macrophages in Sorbs2-deficient hearts: revealing a potential role for macrophage in responding to embryonic myocardial abnormalities by Beibei Hu, Xiangyang Liu, Xiangyang Liu, Xiangyang Liu, Shanshan Xiong, Qin Gong, Junjie Yang, Hongjun Shi, Hongjun Shi, Hongjun Shi, Min Zhang, Fei Liang, Zhen Zhang, Zhen Zhang

    Published 2025-01-01
    “…Macrophages are known to support cardiac development and homeostasis, contributing to tissue remodeling and repair in the adult heart. However, it remains unclear whether embryonic macrophages also respond to abnormalities in the developing heart. …”
    Get full text
    Article
  7. 1107

    Prognostic Significance of Percutaneous Coronary Intervention for First Acute Myocardial Infarction with Heart Failure: Five-Year Follow-Up Results by Zichao Cheng, Yuchen Shi, Hongyu Peng, Donghui Zhao, Qian Fan, Jinghua Liu

    Published 2022-01-01
    “…The study aimed to investigate the incidence and influencing factors of heart failure after 5 years of percutaneous coronary intervention (PCI) for first acute myocardial infarction. …”
    Get full text
    Article
  8. 1108
  9. 1109
  10. 1110
  11. 1111
  12. 1112
  13. 1113
  14. 1114

    Early prediction of in-hospital mortality in patients with congestive heart failure in intensive care unit: a retrospective observational cohort study by Tao Huang, Rui Yang, Jun Lyu, Didi Han, Fengshuo Xu, Shuai Zheng, Luming Zhang, Haiyan Yin

    Published 2022-07-01
    “…Objective Congestive heart failure (CHF) is a clinical syndrome in which the heart disease progresses to a severe stage. …”
    Get full text
    Article
  15. 1115

    A Simple Nomogram to Predict Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure Undergoing Coronary Angiography by Li Lei, Yibo He, Zhaodong Guo, Bowen Liu, Jin Liu, Zhiqiang Nie, Guanzhong Chen, Liwei Liu, Mengfei Lin, Wenhe Yan, Shiqun Chen, Chen Jiyan, Yong Liu

    Published 2021-01-01
    “…Patients with congestive heart failure (CHF) are vulnerable to contrast-induced kidney injury (CI-AKI), but few prediction models are currently available. …”
    Get full text
    Article
  16. 1116

    Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway. by Jing Zhang, Xuefeng Chen, Shilin Lv, Qingqing Hao

    Published 2025-01-01
    “…<h4>Objective</h4>To study the effect of Dapagliflozin on ferroptosis in rabbits with chronic heart failure and to reveal its possible mechanism.…”
    Get full text
    Article
  17. 1117

    Efficacy and Safety of Low-Dose Cyclosporine with Everolimus and Steroids in de novo Heart Transplant Patients: A Multicentre, Randomized Trial by Andreas Zuckermann, Shoei-Shen Wang, Heather Ross, Maria Frigerio, Howard J. Eisen, Christoph Bara, Daniel Hoefer, Maurizio Cotrufo, Gaohong Dong, Guido Junge, Anne M. Keogh

    Published 2011-01-01
    “…A six-month, multicenter, randomized, open-label study was undertaken to determine whether renal function is improved using reduced-exposure cyclosporine (CsA) versus standard-exposure CsA in 199 de novo heart transplant patients receiving everolimus and steroids ± induction therapy. …”
    Get full text
    Article
  18. 1118

    Conversion from Nonshockable to Shockable Rhythms and Out-of-Hospital Cardiac Arrest Outcomes by Initial Heart Rhythm and Rhythm Conversion Time by Wanwan Zhang, Shengyuan Luo, Daya Yang, Yongshu Zhang, Jinli Liao, Liwen Gu, Wankun Li, Zhihao Liu, Yan Xiong, Ahamed Idris

    Published 2020-01-01
    “…There are insufficient data on the prognostic significance of such conversions by initial heart rhythm and different rhythm conversion time. …”
    Get full text
    Article
  19. 1119
  20. 1120